TIF1β activates leukemic transcriptional program in HSCs and promotes BCR::ABL1-induced myeloid leukemia.

MLA

Morii, Mariko, et al. “TIF1β Activates Leukemic Transcriptional Program in HSCs and Promotes BCR::ABL1-Induced Myeloid Leukemia.” Leukemia, vol. 38, no. 6, June 2024, pp. 1275–86. EBSCOhost, https://doi.org/10.1038/s41375-024-02276-w.

APA

Morii, M., Kubota, S., Iimori, M., Yokomizo-Nakano, T., Hamashima, A., Bai, J., Nishimura, A., Tasaki, M., Ando, Y., Araki, K., & Sashida, G. (2024). TIF1β activates leukemic transcriptional program in HSCs and promotes BCR::ABL1-induced myeloid leukemia. Leukemia, 38(6), 1275–1286. https://doi.org/10.1038/s41375-024-02276-w

Chicago

Morii, Mariko, Sho Kubota, Mihoko Iimori, Takako Yokomizo-Nakano, Ai Hamashima, Jie Bai, Akiho Nishimura, et al. 2024. “TIF1β Activates Leukemic Transcriptional Program in HSCs and Promotes BCR::ABL1-Induced Myeloid Leukemia.” Leukemia 38 (6): 1275–86. doi:10.1038/s41375-024-02276-w.